Diseases
- Alzheimer disease (1,530 trials)
- Lung cancer (5,196 trials)
- Pancreatic cancer (1,882 trials)
- Metastatic breast cancer (1,294 trials)
- Colorectal cancer (3,483 trials)
- Liver and biliary tract cancer (2,261 trials)
- Parkinson disease (1,601 trials)
- Long COVID and ME/CFS (453 trials)
- Gastric and esophageal cancer (2,203 trials)
- Multiple myeloma (1,412 trials)
- Glioblastoma (795 trials)
- Ovarian cancer (1,488 trials)
- Acute myeloid leukemia (1,333 trials)
- Multiple sclerosis (1,195 trials)
- Childhood cancers (4,498 trials)
- Prostate cancer (2,788 trials)
- Melanoma (1,226 trials)
- Bladder cancer (1,153 trials)
- Kidney cancer (953 trials)
- Head and neck cancer (1,756 trials)
- Thyroid cancer (471 trials)
- Cervical cancer (991 trials)
- Endometrial cancer (688 trials)
- Triple-negative breast cancer (774 trials)
- Diffuse large B-cell lymphoma (636 trials)
- Hodgkin lymphoma (338 trials)
- Follicular lymphoma (394 trials)
- Mantle cell lymphoma (319 trials)
- Chronic lymphocytic leukaemia (626 trials)
- Acute lymphoblastic leukaemia (991 trials)
- Chronic myeloid leukaemia (372 trials)
- Myelodysplastic syndromes (692 trials)
- Myeloproliferative neoplasms (408 trials)
- Mesothelioma (207 trials)
- Sarcoma (1,044 trials)
- Neuroendocrine tumours (424 trials)
- Neuroblastoma (249 trials)
- ALS (motor neurone disease) (393 trials)
- Huntington's disease (100 trials)
- Epilepsy (782 trials)
- Migraine (553 trials)
- Stroke (4,121 trials)
- Myasthenia gravis (206 trials)
- Spinal muscular atrophy (145 trials)
- Frontotemporal dementia (182 trials)
- Lewy body dementia (137 trials)
- Neuromyelitis optica (NMOSD) (98 trials)
- CIDP (chronic inflammatory demyelinating polyneuropathy) (72 trials)
- Depression (1,207 trials)
- Schizophrenia (916 trials)
- Bipolar disorder (450 trials)
- Autism (947 trials)
- Heart failure (2,317 trials)
- Atrial fibrillation (1,350 trials)
- Coronary artery disease (2,559 trials)
- High blood pressure (2,644 trials)
- Pulmonary arterial hypertension (530 trials)
- Hypertrophic cardiomyopathy (172 trials)
- Amyloidosis (315 trials)
- Type 1 diabetes (1,163 trials)
- Type 2 diabetes (2,875 trials)
- Obesity (4,599 trials)
- Fatty liver disease (MASLD/MASH) (749 trials)
- Familial hypercholesterolaemia (277 trials)
- Osteoporosis (397 trials)
- Chronic kidney disease (1,660 trials)
- IgA nephropathy (162 trials)
- Polycystic kidney disease (90 trials)
- Crohn's disease (731 trials)
- Ulcerative colitis (777 trials)
- Primary biliary cholangitis (91 trials)
- Asthma (1,131 trials)
- COPD (1,275 trials)
- Cystic fibrosis (385 trials)
- Idiopathic pulmonary fibrosis (262 trials)
- Rheumatoid arthritis (769 trials)
- Lupus (SLE) (601 trials)
- Psoriasis (690 trials)
- Psoriatic arthritis (254 trials)
- Ankylosing spondylitis (213 trials)
- Atopic dermatitis (eczema) (651 trials)
- Systemic sclerosis (scleroderma) (341 trials)
- Sjögren's disease (151 trials)
- ANCA-associated vasculitis (140 trials)
- Duchenne muscular dystrophy (187 trials)
- Sickle cell disease (396 trials)
- Haemophilia (285 trials)
- Thalassaemia (168 trials)
- Fabry disease (79 trials)
- Gaucher disease (58 trials)
- Pompe disease (59 trials)
- Friedreich ataxia (48 trials)
- Retinitis pigmentosa (140 trials)
- Macular degeneration (471 trials)
- Glaucoma (471 trials)
- Diabetic eye disease (349 trials)
- HIV (1,904 trials)
- Hepatitis B (431 trials)
- Tuberculosis (433 trials)
- Endometriosis (363 trials)